drugset
drugset / Trial / NCT05874622

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

NCT05874622 ↗

Phase 1 Completed 30 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, dose-escalating, placebo-controlled phase Ib clinical study.

Timeline

Start
2023-06-12
Primary completion
2023-10-18
Completion
2023-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown — —

Indications

rheumatoid arthritis